What is the address of QUAESTOR BIOTECH?

The registered office of QUAESTOR BIOTECH is located at Meensesteenweg 406, 8800 Roeselare.

Is QUAESTOR BIOTECH still active?

Yes. According to the CBE (29 October 2026) QUAESTOR BIOTECH is active, legal situation “Normale toestand”, started on 2 December 2020.

Is QUAESTOR BIOTECH registered on Peppol?

No, QUAESTOR BIOTECH is currently not registered on the Peppol network.

What is the enterprise number of QUAESTOR BIOTECH?

The enterprise number of QUAESTOR BIOTECH is BE0758972936.

When was QUAESTOR BIOTECH founded?

QUAESTOR BIOTECH was founded on 2 December 2020.

Who are the directors of QUAESTOR BIOTECH?

According to the 2025 annual accounts, the directors of QUAESTOR BIOTECH are: Quaestor Vermogensbeheer NV.

Is QUAESTOR BIOTECH a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 December 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did QUAESTOR BIOTECH make in 2025?

QUAESTOR BIOTECH recorded a loss after taxes of € 887,106 in financial year 2025.

What is the revenue of QUAESTOR BIOTECH?

As a small company, QUAESTOR BIOTECH is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -141,949.

How many employees does QUAESTOR BIOTECH have?

According to the 2025 annual accounts, QUAESTOR BIOTECH has 0 full-time equivalents (FTE).

QUAESTOR BIOTECH - Roeselare - BE0758972936

Dossier QUAESTOR BIOTECH, printed on 29 October 2026 from databakkes.be/en/0758972936/quaestor-biotech. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Busy address KBO

57 other companies have their registered office at the same address; threshold 10.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

QUAESTOR BIOTECH from Roeselare, company number BE0758972936, closed financial year 2025 with a result of € -887,106 after tax. For that financial year QUAESTOR BIOTECH recorded a gross margin of € -141,949 and equity of € 13 million. Compared with financial year 2024, the result moved from € 92,110 to € -887,106. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.

What it is worth Growing

€ 13 million

▲ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -887,106

▼ still € 92,110 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.1 million

▼ 17% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -2.2 million.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 68,466

▲ 1% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -105,162 Gross margin 2022: € -105,162 First fiscal year in the series	€ -113,714 Gross margin 2023: € -113,714 ▼ € 8,552 vs 2022 (€ -105,162) Unfavourable step	€ -132,175 Gross margin 2024: € -132,175 ▼ € 18,461 vs 2023 (€ -113,714) Unfavourable step	€ -141,949 Gross margin 2025: € -141,949 ▼ € 9,774 vs 2024 (€ -132,175) Unfavourable step	▼ € 9,774
Profit after taxes	€ -310,355 Profit after taxes 2022: € -310,355 First fiscal year in the series	€ -354,729 Profit after taxes 2023: € -354,729 ▼ € 44,374 vs 2022 (€ -310,355) Unfavourable step	€ 92,110 Profit after taxes 2024: € 92,110 ▲ € 446,839 vs 2023 (€ -354,729) Favourable step	€ -887,106 Profit after taxes 2025: € -887,106 ▼ € 979,216 vs 2024 (€ 92,110) Unfavourable step	▼ € 979,216
Equity	€ 9,480,057 Equity 2022: € 9,480,057 First fiscal year in the series	€ 9,125,328 Equity 2023: € 9,125,328 ▼ 4% vs 2022 (€ 9,480,057) Unfavourable step	€ 11,547,438 Equity 2024: € 11,547,438 ▲ 27% vs 2023 (€ 9,125,328) Favourable step	€ 12,990,332 Equity 2025: € 12,990,332 ▲ 12% vs 2024 (€ 11,547,438) Favourable step	▲ 12%
Total debts	€ 67,391 Total debts 2022: € 67,391 First fiscal year in the series	€ 28,031 Total debts 2023: € 28,031 ▼ 58% vs 2022 (€ 67,391) Favourable step	€ 67,726 Total debts 2024: € 67,726 ▲ 142% vs 2023 (€ 28,031) Unfavourable step	€ 68,466 Total debts 2025: € 68,466 ▲ 1% vs 2024 (€ 67,726) Unfavourable step	▲ 1%
Cash	€ 2,576,217 Cash 2022: € 2,576,217 First fiscal year in the series	€ 35,497 Cash 2023: € 35,497 ▼ 99% vs 2022 (€ 2,576,217) Unfavourable step	€ 1,345,533 Cash 2024: € 1,345,533 ▲ € 1.3 million vs 2023 (€ 35,497) Favourable step	€ 1,116,231 Cash 2025: € 1,116,231 ▼ 17% vs 2024 (€ 1,345,533) Unfavourable step	▼ 17%
Retained profit	€ -1,086,693 Retained profit 2022: € -1,086,693 First fiscal year in the series	€ -1,441,422 Retained profit 2023: € -1,441,422 ▼ € 354,729 vs 2022 (€ -1,086,693) Unfavourable step	€ -1,349,312 Retained profit 2024: € -1,349,312 ▲ € 92,110 vs 2023 (€ -1,441,422) Favourable step	€ -2,236,418 Retained profit 2025: € -2,236,418 ▼ € 887,106 vs 2024 (€ -1,349,312) Unfavourable step	▼ € 887,106
Balance sheet total	€ 9,547,448 Balance sheet total 2022: € 9,547,448 First fiscal year in the series	€ 9,153,359 Balance sheet total 2023: € 9,153,359 ▼ 4% vs 2022 (€ 9,547,448) Unchanged	€ 11,615,164 Balance sheet total 2024: € 11,615,164 ▲ 27% vs 2023 (€ 9,153,359) Unchanged	€ 13,058,798 Balance sheet total 2025: € 13,058,798 ▲ 12% vs 2024 (€ 11,615,164) Unchanged	▲ 12%

Key figures of QUAESTOR BIOTECH, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to QUAESTOR BIOTECH?

What happened at QUAESTOR BIOTECH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 27, 2026 New annual accounts for financial year 2025: loss of € 887,106 (▼ € 979,216 vs 2024). Source: NBB ↗
Dec 2, 2020 New establishment in Roeselare. KBO
Dec 2, 2020 Start of the company according to the CBE. KBO

In short

From € 310,355 loss in 2022 to € 887,106 loss in 2025.

Paid € 253 in corporate taxes since 2022.

Best year ever: 2024, with € 92,110 profit.

Original PDFs at the National Bank ↗

Management

Quaestor Vermogensbeheer NV

QUAESTOR BIOTECH

DGD LP II 19.3%

Novalis II 16.8%

OMXE Partners 16.7%

OMXE Invest 11.1%

Behind QUAESTOR BIOTECH is Quaestor Vermogensbeheer NV. It owns 19.3% of DGD LP II, 16.8% of Novalis II, 16.7% of OMXE Partners and 11.1% of OMXE Invest itself.

Directors

According to the 2025 annual accounts

Quaestor Vermogensbeheer NV

Manager · represented by Lode Langedock

Also active at: QUAESTOR PRIVATE EQUITY, Quaestor D2E II Participatie, QUAESTOR GCP II, Quaestor S V, Quaestor HV4/HOF2, QUAESTOR FS II, QUAESTOR E V, QUAESTOR V IV +26 more

Establishments

Establishment units

Physical locations of this company

Registered office

Meensesteenweg 406

8800 Roeselare

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 57 companies are registered at this address.

All companies at this address →

Quaestor Vermogensbeheer same network

Quaestor Rentmeesters

€ 705,525 gross margin · 2025

Quaestor Insurance

€ 26,017 gross margin · 2025

Quaestor General Partner

€ -1,984 gross margin · 2025

QUAESTOR PRIVATE EQUITY same network

€ -260,478 gross margin · 2025

+52 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0758.972.936
VAT number: BE 0758.972.936
Registered office: Meensesteenweg 406, 8800 Roeselare
Names & denominations: QUAESTOR BIOTECH
Enterprise type: Rechtspersoon
Legal form: Limited partnership
Legal situation: Normale toestand
Start date: 2 December 2020
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗